Alkahest

Biopharma company founded in 2014 in San Carlos, California, acquired by Grifols in 2020. Alkahest studies plasma-derived proteins and signaling factors to treat neurological and systemic age-related diseases. Its research into the “chronokine” axis focuses on cognitive decline, inflammation, and neurodegeneration. (alkahest.com)...